RAPP
Rapport Therapeutics, Inc. Common Stock$25.05+0.83 (+3.45%)Prev Close$24.21·MCap$1.24B·P/E—·Vol526.4K·Yield—
▲
Buys (12M)
7
$22.02M
▼
Sells (12M)
36
$47.79M
◆
Net Activity
Net Seller
$25.76M
●
Active Insiders
12
last 12 mo
Over the past 12 months, insider activity at Rapport Therapeutics, Inc. Common Stock (RAPP) has been dominated by selling, with 7 insider purchases totaling $22.02M and 36 insider sales totaling $47.79M. The most recent insider transaction was by HEALY JAMES (director), who purchased $20.36M worth of shares on Oct 30, 2026. Rapport Therapeutics, Inc. Common Stock operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.24B.
RAPP Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 30, 2026 | HEALY JAMES | director | Buy | 969,480 | $21.00 | $20.36M2.0% OS | 2,815,707+53% |
| Oct 23, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 2,210 | $29.16 | $64.4K | 450,035 |
| Oct 23, 2026 | Sanchez Ramiro | director | Buy | 3,600 | $27.35 | $98.5K | 3,600 |
| Oct 22, 2026 | Silva Paul M | director | Buy | 3,680 | $27.08 | $99.6K | 3,680 |
| Oct 22, 2026 | Young Wendy B. | director | Buy | 3,789 | $26.39 | $100.0K | 13,289+40% |
| Oct 22, 2026 | MARAGANORE JOHN | director | Buy | 9,411 | $26.45 | $248.9K | 9,411 |
| Oct 22, 2026 | PAUL STEVEN M | director | Buy | 35,714 | $27.28 | $974.3K | 77,380+86% |
| Oct 21, 2026 | Ignelzi Troy A. | officer: Chief Financial Officer | Buy | 5,500 | $26.10 | $143.6K | 15,500+55% |
| Oct 8, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 4,522 | $31.68 | $143.3K | 453,392 |
| Oct 1, 2026 | Gault Cheryl | officer: Chief Operating Officer | Sell | 10,000 | $33.19 | $331.9K | 141,989 |
| Sep 24, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 2,210 | $39.17 | $86.6K | 457,025 |
| Sep 9, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 8,210 | $45.61 | $374.5K | 460,046 |
| Aug 26, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 18,921 | $49.57 | $938.0K | 467,187 |
| Aug 26, 2026 | Yeleswaram Krishnaswamy | officer: Chief Development Officer | Sell | 50,160 | $50.47 | $2.53M | 232,862 |
| Aug 20, 2026 | Yeleswaram Krishnaswamy | officer: Chief Development Officer | Sell | 404 | $49.90 | $20.2K | 246,022 |
| Aug 12, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 51,499 | $47.25 | $2.43M | 523,436 |
| Jul 29, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 2,210 | $42.11 | $93.1K | 537,614 |
| Jul 15, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 8,210 | $40.00 | $328.4K | 542,546 |
| Jul 1, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 8,220 | $39.83 | $327.4K | 548,903 |
| Jul 1, 2026 | Gault Cheryl | officer: Chief Operating Officer | Sell | 10,000 | $41.58 | $415.8K | 158,014 |
| May 28, 2026 | Third Rock Ventures V, L.P. | 10 percent owner | Sell | 18,572 | $40.05 | $743.8K | 6,280,525 |
| May 13, 2026 | Third Rock Ventures V, L.P. | 10 percent owner | Sell | 133,618 | $40.24 | $5.38M | 6,299,097 |
| May 11, 2026 | Third Rock Ventures V, L.P. | 10 percent owner | Sell | 276,513 | $40.12 | $11.09M0.8% OS | 6,437,733 |
| Apr 21, 2026 | Third Rock Ventures V, L.P. | 10 percent owner | Sell | 426,005 | $40.32 | $17.18M1.2% OS | 6,709,228 |
| Apr 21, 2026 | Yeleswaram Krishnaswamy | officer: Chief Development Officer | Sell | 20,225 | $39.99 | $808.8K | 246,426 |
| Apr 14, 2026 | Yeleswaram Krishnaswamy | officer: Chief Development Officer | Sell | 19,865 | $35.03 | $695.8K | 286,016 |
| Apr 9, 2026 | Yeleswaram Krishnaswamy | officer: Chief Development Officer | Sell | 360 | $34.90 | $12.6K | 286,516 |
| Mar 31, 2026 | Gault Cheryl | officer: Chief Operating Officer | Sell | 10,000 | $28.19 | $281.9K | 162,753 |
| Mar 26, 2026 | Yeleswaram Krishnaswamy | officer: Chief Development Officer | Sell | 10,115 | $29.99 | $303.4K | 286,876 |
| Mar 9, 2026 | Gault Cheryl | officer: Chief Operating Officer | Sell | 2,014 | $28.93 | $58.3K | 169,914 |
| Feb 19, 2026 | Bredt David | officer: Chief Scientific Officer | Sell | 8,500 | $29.02 | $246.7K | 394,675 |
| Feb 19, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 10,916 | $29.35 | $320.4K | 558,528 |
| Feb 18, 2026 | Ceesay Abraham | Chief Executive Officer | Sell | 10,916 | $29.35 | $320.4K | 0 |
| Feb 17, 2026 | Bredt David | Chief Scientific Officer | Sell | 8,500 | $29.02 | $246.7K | 0 |
| Jan 22, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 10,916 | $26.11 | $285.1K | 562,080 |
| Jan 16, 2026 | Bredt David | officer: Chief Scientific Officer | Sell | 8,500 | $26.84 | $228.1K | 395,775 |
| Jan 5, 2026 | Bredt David | officer: Chief Scientific Officer | Sell | 6,567 | $30.05 | $197.3K | 404,075 |
| Jan 5, 2026 | Yeleswaram Krishnaswamy | officer: Chief Development Officer | Sell | 2,840 | $30.05 | $85.3K | 296,991 |
| Dec 18, 2025 | Ceesay Abraham | Chief Executive Officer | Sell | 10,916 | $29.64 | $323.5K | 571,305 |
| Dec 16, 2025 | Bredt David | Chief Scientific Officer | Sell | 8,500 | $30.02 | $255.1K | 393,438 |
| Dec 1, 2025 | Gault Cheryl | Chief Operating Officer | Sell | 5,000 | $30.10 | $150.5K | 171,928 |
| Nov 18, 2025 | Bredt David | Chief Scientific Officer | Sell | 8,500 | $25.19 | $214.1K | 406,486 |
| Nov 18, 2025 | Ceesay Abraham | Chief Executive Officer | Sell | 10,916 | $25.20 | $275.0K | 576,802 |
| Oct 16, 2025 | Bredt David | Chief Scientific Officer | Sell | 8,500 | $25.79 | $219.2K | 410,724 |
| Oct 16, 2025 | Ceesay Abraham | Chief Executive Officer | Sell | 10,916 | $25.81 | $281.7K | 580,765 |
| Sep 19, 2025 | Ceesay Abraham | Chief Executive Officer | Sell | 76,420 | $26.32 | $2.01M | 586,812 |
| Sep 17, 2025 | Bredt David | Chief Scientific Officer | Sell | 8,500 | $24.19 | $205.6K | 421,544 |
| Sep 15, 2025 | Huber Reid M | Buy | 20,400 | $24.48 | $499.4K | 20,400 | |
| Sep 15, 2025 | PAUL STEVEN M | Buy | 41,666 | $24.65 | $1.03M | 41,666 | |
| Sep 11, 2025 | Young Wendy B. | Buy | 3,500 | $22.60 | $79.1K | 9,500+58% |
Showing 1–50 of 61
1 / 2
RAPP Insider Buying Activity
The following table shows recent insider purchases of Rapport Therapeutics, Inc. Common Stock (RAPP) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 30, 2026 | HEALY JAMES | director | Buy | 969,480 | $21.00 | $20.36M2.0% OS | 2,815,707+53% |
| Oct 23, 2026 | Sanchez Ramiro | director | Buy | 3,600 | $27.35 | $98.5K | 3,600 |
| Oct 22, 2026 | Silva Paul M | director | Buy | 3,680 | $27.08 | $99.6K | 3,680 |
| Oct 22, 2026 | Young Wendy B. | director | Buy | 3,789 | $26.39 | $100.0K | 13,289+40% |
| Oct 22, 2026 | MARAGANORE JOHN | director | Buy | 9,411 | $26.45 | $248.9K | 9,411 |
| Oct 22, 2026 | PAUL STEVEN M | director | Buy | 35,714 | $27.28 | $974.3K | 77,380+86% |
| Oct 21, 2026 | Ignelzi Troy A. | officer: Chief Financial Officer | Buy | 5,500 | $26.10 | $143.6K | 15,500+55% |
| Sep 15, 2025 | Huber Reid M | Buy | 20,400 | $24.48 | $499.4K | 20,400 | |
| Sep 15, 2025 | PAUL STEVEN M | Buy | 41,666 | $24.65 | $1.03M | 41,666 | |
| Sep 11, 2025 | Young Wendy B. | Buy | 3,500 | $22.60 | $79.1K | 9,500+58% |
RAPP Insider Selling Activity
The following table shows recent insider sales of Rapport Therapeutics, Inc. Common Stock (RAPP) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 23, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 2,210 | $29.16 | $64.4K | 450,035 |
| Oct 8, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 4,522 | $31.68 | $143.3K | 453,392 |
| Oct 1, 2026 | Gault Cheryl | officer: Chief Operating Officer | Sell | 10,000 | $33.19 | $331.9K | 141,989 |
| Sep 24, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 2,210 | $39.17 | $86.6K | 457,025 |
| Sep 9, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 8,210 | $45.61 | $374.5K | 460,046 |
| Aug 26, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 18,921 | $49.57 | $938.0K | 467,187 |
| Aug 26, 2026 | Yeleswaram Krishnaswamy | officer: Chief Development Officer | Sell | 50,160 | $50.47 | $2.53M | 232,862 |
| Aug 20, 2026 | Yeleswaram Krishnaswamy | officer: Chief Development Officer | Sell | 404 | $49.90 | $20.2K | 246,022 |
| Aug 12, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 51,499 | $47.25 | $2.43M | 523,436 |
| Jul 29, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 2,210 | $42.11 | $93.1K | 537,614 |
| Jul 15, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 8,210 | $40.00 | $328.4K | 542,546 |
| Jul 1, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 8,220 | $39.83 | $327.4K | 548,903 |
| Jul 1, 2026 | Gault Cheryl | officer: Chief Operating Officer | Sell | 10,000 | $41.58 | $415.8K | 158,014 |
| May 28, 2026 | Third Rock Ventures V, L.P. | 10 percent owner | Sell | 18,572 | $40.05 | $743.8K | 6,280,525 |
| May 13, 2026 | Third Rock Ventures V, L.P. | 10 percent owner | Sell | 133,618 | $40.24 | $5.38M | 6,299,097 |
| May 11, 2026 | Third Rock Ventures V, L.P. | 10 percent owner | Sell | 276,513 | $40.12 | $11.09M0.8% OS | 6,437,733 |
| Apr 21, 2026 | Third Rock Ventures V, L.P. | 10 percent owner | Sell | 426,005 | $40.32 | $17.18M1.2% OS | 6,709,228 |
| Apr 21, 2026 | Yeleswaram Krishnaswamy | officer: Chief Development Officer | Sell | 20,225 | $39.99 | $808.8K | 246,426 |
| Apr 14, 2026 | Yeleswaram Krishnaswamy | officer: Chief Development Officer | Sell | 19,865 | $35.03 | $695.8K | 286,016 |
| Apr 9, 2026 | Yeleswaram Krishnaswamy | officer: Chief Development Officer | Sell | 360 | $34.90 | $12.6K | 286,516 |
| Mar 31, 2026 | Gault Cheryl | officer: Chief Operating Officer | Sell | 10,000 | $28.19 | $281.9K | 162,753 |
| Mar 26, 2026 | Yeleswaram Krishnaswamy | officer: Chief Development Officer | Sell | 10,115 | $29.99 | $303.4K | 286,876 |
| Mar 9, 2026 | Gault Cheryl | officer: Chief Operating Officer | Sell | 2,014 | $28.93 | $58.3K | 169,914 |
| Feb 19, 2026 | Bredt David | officer: Chief Scientific Officer | Sell | 8,500 | $29.02 | $246.7K | 394,675 |
| Feb 19, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 10,916 | $29.35 | $320.4K | 558,528 |
| Feb 18, 2026 | Ceesay Abraham | Chief Executive Officer | Sell | 10,916 | $29.35 | $320.4K | 0 |
| Feb 17, 2026 | Bredt David | Chief Scientific Officer | Sell | 8,500 | $29.02 | $246.7K | 0 |
| Jan 22, 2026 | Ceesay Abraham | director, officer: Chief Executive Officer | Sell | 10,916 | $26.11 | $285.1K | 562,080 |
| Jan 16, 2026 | Bredt David | officer: Chief Scientific Officer | Sell | 8,500 | $26.84 | $228.1K | 395,775 |
| Jan 5, 2026 | Bredt David | officer: Chief Scientific Officer | Sell | 6,567 | $30.05 | $197.3K | 404,075 |
| Jan 5, 2026 | Yeleswaram Krishnaswamy | officer: Chief Development Officer | Sell | 2,840 | $30.05 | $85.3K | 296,991 |
| Dec 18, 2025 | Ceesay Abraham | Chief Executive Officer | Sell | 10,916 | $29.64 | $323.5K | 571,305 |
| Dec 16, 2025 | Bredt David | Chief Scientific Officer | Sell | 8,500 | $30.02 | $255.1K | 393,438 |
| Dec 1, 2025 | Gault Cheryl | Chief Operating Officer | Sell | 5,000 | $30.10 | $150.5K | 171,928 |
| Nov 18, 2025 | Bredt David | Chief Scientific Officer | Sell | 8,500 | $25.19 | $214.1K | 406,486 |
| Nov 18, 2025 | Ceesay Abraham | Chief Executive Officer | Sell | 10,916 | $25.20 | $275.0K | 576,802 |
| Oct 16, 2025 | Bredt David | Chief Scientific Officer | Sell | 8,500 | $25.79 | $219.2K | 410,724 |
| Oct 16, 2025 | Ceesay Abraham | Chief Executive Officer | Sell | 10,916 | $25.81 | $281.7K | 580,765 |
| Sep 19, 2025 | Ceesay Abraham | Chief Executive Officer | Sell | 76,420 | $26.32 | $2.01M | 586,812 |
| Sep 17, 2025 | Bredt David | Chief Scientific Officer | Sell | 8,500 | $24.19 | $205.6K | 421,544 |
RAPP Insiders
Similar Stocks to RAPP
MRNA
Moderna, Inc.
$219.87-1.26%
$85.50B
REGN
Regeneron Pharmaceuticals, Inc.
$923.97+12.96%
$83.15B
RVMD
Revolution Medicines, Inc.
$190.97+0.34%
$39.42B
ALNY
Alnylam Pharmaceuticals, Inc.
$164.06-6.11%
$30.46B
UTHR
United Therapeutics Corporation
$601.25+1.30%
$25.15B
INCY
Incyte Corporation
$120.39+2.95%
$23.69B
INSM
Insmed Incorporated
$112.45+0.83%
$21.18B
EXEL
Exelixis, Inc.
$69.81+5.44%
$16.64B